Table 2.
Association Between Clinical Characteristics and COVID-19 Diagnoses Among Dialysis Patients
| OR (95% CI) | P | |
|---|---|---|
| Age | ||
| 60-69 y | 1.14 (0.80-1.64) | 0.5 |
| 70-79 y | 1.14 (0.78-1.65) | 0.5 |
| ≥80 y | 1.16 (0.75-1.78) | 0.5 |
| Male sex | 1.35 (1.09-1.68) | 0.01a |
| Black vs White race | 1.95 (1.51-2.50) | <0.001a |
| Other race vs White race | 1.27 (0.91-1.77) | 0.2 |
| Home dialysis | 0.51 (0.31-0.82) | 0.01a |
| Urban clinic | 2.30 (1.50-3.52) | 0.001a |
| Congregate setting | 17.10 (13.51-21.54) | <0.001a |
| Albumin <3.5 g/dL | 0.88 (0.66-1.17) | 0.3 |
| Inhaled respiratory agents | 1.15 (0.89-1.49) | 0.3 |
| No. of comorbiditiesb | 0.89 (0.81-0.97) | 0.01a |
| Diabetes mellitus | 1.36 (1.06-1.75) | 0.02a |
| Hypertension | 0.91 (0.67-1.22) | 0.5 |
| Atherosclerotic heart disease | 1.42 (1.04-1.94) | 0.03a |
| Stroke | 1.03 (0.72-1.47) | 0.9 |
| Assistance with ADL | 1.33 (0.39-4.48) | 0.7 |
| Wheelchair use | 0.89 (0.48-1.66) | 0.7 |
Entry in the logistic model requires P < 0.1 in univariate analysis, except for sex, which was forced in. N = 7,948. Abbreviation: ADL, activities of daily living.
Statistically significant.
Relative risk per additional comorbid illness category among comorbidities listed in Table 1.